Ajanta Pharma has issued a revised schedule for upcoming analyst and institutional investor meetings. The company clarified that the dates for two key investor conferences were inadvertently interchanged in a previous communication. Management remains committed to discussing only publicly available information during these upcoming engagements, ensuring transparency as they interact with stakeholders at these scheduled events.
Correction of Investor Meeting Timeline
Ajanta Pharma has provided an update to its investor outreach schedule to rectify a clerical error regarding meeting dates. The company confirmed that the dates for two significant investor conferences were previously interchanged and have now been corrected to ensure accurate coordination with the investment community.
Updated Conference Details
The corrected schedule for the upcoming investor engagements is as follows:
- 360 ONE Capital (B&K) Annual Investor Conference: Scheduled for May 29, 2026, to be held at the Grand Hyatt, Santacruz.
- ICICI Securities India Investor Conference: Scheduled for June 8, 2026.
Commitment to Transparency
Ajanta Pharma emphasized that these meetings are subject to change due to unforeseen exigencies. Furthermore, the company has reiterated that all discussions held during these sessions will be strictly limited to information that has already been made available in the public domain, maintaining compliance with disclosure standards.
Source: BSE
